![Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell Carcinoma of the Oropharnyx | Anticancer Research Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell Carcinoma of the Oropharnyx | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/30/6/2291/F2.large.jpg)
Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell Carcinoma of the Oropharnyx | Anticancer Research
![A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04329265-57d4-43e6-98ae-48514c4ac38f/jcla21597-fig-0001-m.jpg)
A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum - He - 2013 - Journal of Clinical Laboratory Analysis - Wiley Online Library
![PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bdba421605be5e232b261c12588773538791f229/3-Table4-1.png)
PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar
![New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs11671-020-3247-9/MediaObjects/11671_2020_3247_Sch3_HTML.png)
New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite | Discover Nano
![CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6601851/MediaObjects/41416_2004_Article_BF6601851_Fig1_HTML.gif)
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer
![Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram](https://www.researchgate.net/publication/15660046/figure/tbl1/AS:601648456028177@1520455578619/Relationship-of-CYFRA-21-1-to-the-histo-logical-type-of-NSCLC-and-the-stage-of-disease.png)
Relationship of CYFRA 21-1 to the histo- logical type of NSCLC and the... | Download Scientific Diagram
![Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer](https://www.spandidos-publications.com/article_images/etm/6/2/ETM-06-02-0355-g00.jpg)
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
![Table 6 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar Table 6 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9cbea13732ed9f9299e409d9fb7b272385d2ae69/9-Table6-1.png)
Table 6 from Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis | Semantic Scholar
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
![The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/35/10/5519/F1.large.jpg)
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research
![Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/29/8/3421/F6.large.jpg)